Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Arachidonate 5-lipoxygenase | Starlite/ChEMBL | References |
Homo sapiens | arachidonate 5-lipoxygenase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | arachidonate 5 lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma japonicum | ko:K00461 arachidonate 5-lipoxygenase [EC1.13.11.34], putative | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma japonicum | IPR001024,Lipoxygenase, LH2;IPR013819,Lipoxygenase, C-terminal,domain-containing | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma mansoni | lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma mansoni | lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Doublecortin family protein | 0.0048 | 0.0686 | 0.0686 |
Brugia malayi | RNA binding protein | 0.0196 | 0.3665 | 0.3665 |
Schistosoma mansoni | lipoxygenase | 0.0199 | 0.3734 | 0.5382 |
Schistosoma mansoni | polycystin 1-related | 0.0048 | 0.0686 | 0.0715 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0048 | 0.0686 | 0.0891 |
Brugia malayi | hypothetical protein | 0.0048 | 0.0686 | 0.0686 |
Brugia malayi | MH2 domain containing protein | 0.0358 | 0.6933 | 0.6933 |
Schistosoma mansoni | hypothetical protein | 0.0162 | 0.2978 | 0.4225 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0686 | 0.0686 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0024 | 0.0218 | 0.5 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0175 | 0.325 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0196 | 0.3665 | 0.6576 |
Echinococcus multilocularis | GPCR, family 2 | 0.0162 | 0.2978 | 0.5266 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0048 | 0.0686 | 1 |
Brugia malayi | Smad1 | 0.0024 | 0.0219 | 0.0219 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0048 | 0.0686 | 0.0891 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0162 | 0.2978 | 0.2978 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0024 | 0.0219 | 0.0219 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0162 | 0.2978 | 0.5266 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0218 | 0.0218 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0045 | 0.0045 |
Echinococcus multilocularis | tar DNA binding protein | 0.0196 | 0.3665 | 0.6576 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0162 | 0.2978 | 0.5266 |
Brugia malayi | MH1 domain containing protein | 0.0024 | 0.0219 | 0.0219 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0024 | 0.0218 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0024 | 0.0219 | 0.0219 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0358 | 0.6933 | 0.6933 |
Schistosoma mansoni | tar DNA-binding protein | 0.0196 | 0.3665 | 0.5275 |
Schistosoma mansoni | rab6-interacting | 0.0048 | 0.0686 | 0.0715 |
Brugia malayi | MH1 domain containing protein | 0.0024 | 0.0219 | 0.0219 |
Schistosoma mansoni | hypothetical protein | 0.0349 | 0.675 | 1 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0048 | 0.0686 | 0.0891 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0285 | 0.5459 | 1 |
Brugia malayi | TAR-binding protein | 0.0196 | 0.3665 | 0.3665 |
Loa Loa (eye worm) | doublecortin family protein | 0.0048 | 0.0686 | 0.0686 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0024 | 0.0218 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0024 | 0.0219 | 0.0219 |
Loa Loa (eye worm) | Smad1 | 0.0024 | 0.0219 | 0.0219 |
Schistosoma mansoni | lipoxygenase | 0.0285 | 0.5459 | 0.8023 |
Echinococcus granulosus | GPCR family 2 | 0.0162 | 0.2978 | 0.5266 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0162 | 0.2978 | 0.5266 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0024 | 0.0218 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0686 | 0.0715 |
Echinococcus multilocularis | RUN | 0.0048 | 0.0686 | 0.0891 |
Leishmania major | hypothetical protein, conserved | 0.0024 | 0.0218 | 0.5 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0162 | 0.2978 | 0.2978 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0285 | 0.5459 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0196 | 0.3665 | 0.3665 |
Brugia malayi | N-terminal motif family protein | 0.0175 | 0.325 | 0.325 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0162 | 0.2978 | 0.5266 |
Schistosoma mansoni | tar DNA-binding protein | 0.0196 | 0.3665 | 0.5275 |
Schistosoma mansoni | tar DNA-binding protein | 0.0196 | 0.3665 | 0.5275 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0048 | 0.0686 | 0.0891 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0024 | 0.0219 | 0.0219 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0686 | 0.0686 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0196 | 0.3665 | 0.3665 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0196 | 0.3665 | 0.3665 |
Schistosoma mansoni | rab6-interacting | 0.0048 | 0.0686 | 0.0715 |
Loa Loa (eye worm) | hypothetical protein | 0.0175 | 0.325 | 0.325 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0511 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0218 | 0.0218 |
Schistosoma mansoni | loxhd1 | 0.0048 | 0.0686 | 0.0715 |
Loa Loa (eye worm) | hypothetical protein | 0.0162 | 0.2978 | 0.2978 |
Loa Loa (eye worm) | hypothetical protein | 0.0349 | 0.675 | 0.675 |
Schistosoma mansoni | hypothetical protein | 0.0162 | 0.2978 | 0.4225 |
Schistosoma mansoni | tar DNA-binding protein | 0.0196 | 0.3665 | 0.5275 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.0048 | 0.0686 | 0.0891 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.0048 | 0.0686 | 0.0891 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0511 | 1 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0358 | 0.6933 | 0.6933 |
Loa Loa (eye worm) | hypothetical protein | 0.0511 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0048 | 0.0686 | 0.0686 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0162 | 0.2978 | 0.2978 |
Echinococcus granulosus | RUN | 0.0048 | 0.0686 | 0.0891 |
Loa Loa (eye worm) | TAR-binding protein | 0.0196 | 0.3665 | 0.3665 |
Schistosoma mansoni | hypothetical protein | 0.0162 | 0.2978 | 0.4225 |
Schistosoma mansoni | hypothetical protein | 0.0162 | 0.2978 | 0.4225 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0349 | 0.675 | 0.675 |
Schistosoma mansoni | tar DNA-binding protein | 0.0196 | 0.3665 | 0.5275 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0048 | 0.0686 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 28 nM | In vitro inhibition of LTB4 biosynthesis in [Ca2+]-ionophore-activated human polymorphonuclear leukocytes | ChEMBL. | 8410991 |
IC50 (functional) | = 28 nM | In vitro inhibition of LTB4 biosynthesis in [Ca2+]-ionophore-activated human polymorphonuclear leukocytes | ChEMBL. | 8410991 |
IC50 (binding) | = 40 nM | In vitro test for inhibition of 5-lipoxygenase in cell-free preparations from rat PMN leukocytes | ChEMBL. | 8410991 |
IC50 (binding) | = 40 nM | In vitro test for inhibition of 5-lipoxygenase in cell-free preparations from rat PMN leukocytes | ChEMBL. | 8410991 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.